|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. REFERENCESAli, J., L. Rodrigues, and M. Moodie. 1997. U.S. Chemical-Biological Defense Guidebook. Alexandria, Va.: Jane’s Information Group. Boyle, R.E. 1998. U.S. Chemical Warfare: A Historical Perspective. LG-1597. Albuquerque, N.Mex.: Sandia National Laboratories. Johnson, K.M. 1990. “Marburg and Ebola Viruses.” In Principles and Practice of Infectious Diseases, 3rd Ed. New York: Churchill Livingstone, pp. 1303-1306. LeDuc, J.W. 1989. “Epidemiology of Hemorrhagic Fever Viruses.” Reviews of Infectious Diseases 11(Supp.4): S730-S725. Mikolich, D.J., and J.M. Boyce. 1990. “Brucella Species.” In Principles and Practice of Infectious Diseases, 3rd Ed. New York: Churchill Livingstone, pp. 1735-1742. NATO (North Atlantic Treaty Organization). 1996. NATO Handbook on the Medical Aspects of NBC Defense Operations. Part III. Chemical. AMed P-6(B). Washington, D.C.: U.S. Government Printing Office. NRC (National Research Council). 1997. Review of Acute Human-Toxicity Estimate for Selected Chemical-Warfare Agents . Washington, D.C.: National Academy Press. U.S. Air Force. 1997. USAF Operations in a Chemical and Biological (CB) Warfare Environment, CB Hazards. Air Force Handbook 32-4014, Vol. 2. Washington, D.C.: Department of the Air Force. U.S. Army. 1995. Medical Management of Chemical Casualties Handbook. Aberdeen Proving Ground, Md.: Medical Research Institute of Chemical Defense, Chemical Casualty Care Office. U.S. Army, U.S. Navy, and U.S. Air Force. 1990. Potential Military Chemical/Biological Agents and Compounds. Army Field Manual 3-9, Navy Publication P-467, and Air Force Manual 355-7. Washington, D.C.: Department of the Army/Department of the Navy/Department of the Air Force.
|
|
|||||||||||||||
